- Grom Social Enterprises (GROM) +58%.
- MicroCloud Hologram (HOLO) +40%.
- Intelligent Bio Solutions (INBS) +24%.
- Baudax Bio (BXRX) +20% announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000.
- CymaBay Therapeutics (CBAY) +11% gains on pricing of $85.05M public offering.
- Draganfly (DPRO) +10%.
- Aridis Pharmaceuticals (ARDS) +9%.
- Apexigen (APGN) +7%.
- HEXO (HEXO) +7%.
- Allogene Therapeutics (ALLO) +7%.
- Can-Fite BioPharma (CANF) +9% Namodenoson Significantly Inhibits Pancreatic Cancer in Preclinical Studies—A Patent Has Been Filed.
- Biora Therapeutics (BIOR) +6%.
- American Lithium (AMLI) +6% announces Royalty Buyback at its TLC Lithium Project in Nevada.
- Bed Bath & Beyond (BBBY) +6%.
- Argo Blockchain (ARBK) +6%.
- Sasol Limited (SSL) +5% PRODUCTION AND SALES METRICS FOR THE SIX MONTHS ENDED 31 DECEMBER 2022; UPDATE ON RENEWABLE POWER INTEGRATION IN SOUTH AFRICAN OPERATIONS.